Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07333430 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A Phase 1a/1b Open-Label Study with Dose Escalation and Expansion Phases to Evaluate Safety and Preliminary Efficacy of Naïve HBI0101 CART Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma.
Trial Details
NCT Number NCT07333430
Lead Sponsor Hadassah Medical Organization
Conditions
(from sponsor)		 Relapsed/Refractory Multiple Myeloma (MM)
Related terms Multiple Myeloma
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov